OSI Systems
Builds security-screening systems, optoelectronic components, and hospital patient-monitoring equipment.
Something off on this page? Send us feedback.
Profile
Sells security-screening equipment and turnkey inspection services, optoelectronic components and contract manufacturing, and Spacelabs patient-monitoring and cardiology systems. Security generates most revenue, while vertical integration links component production with finished systems and services.
Designs and manufactures security-inspection systems, optoelectronic components, electronics assemblies, and hospital monitoring products across three divisions. Rapiscan equipment screens baggage, people, cargo, and vehicles, while S2 supplies software and turnkey checkpoint operations.
Produces sensors, laser devices, flex circuits, and other assemblies for internal divisions and OEMs through Optoelectronics and Manufacturing. Spacelabs Healthcare provides bedside and telemetry monitoring, diagnostic cardiology, remote monitoring, and connected-care systems.
Combines in-house component production with final systems, software, maintenance, and staffed screening services for customers across the Americas, Europe, the Middle East, and Asia-Pacific. Security generates most revenue, leaving results tied to government procurement, customer acceptance, export controls, medical-device regulation, and certain single-source components.
Company facts
Key statistics
Year to date −19.1% · Average volume (30d) 251.8K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 21, 2026 | Roth Capital | Reiterate | Buy | $310 | $274 |
| Aug 21, 2026 | Oppenheimer | Reiterate | Outperform | $280 | $300 |
| May 5, 2026 | Roth Capital | Target | $295 | $310 | |
| Jan 30, 2026 | Roth Capital | Reiterate | Buy | $292 | $295 |
| Dec 1, 2025 | UBS | Target | $292 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026Q4 FY26 | $3.77 | $3.78 | +0.3% | $529.7M | $484.1M | −8.6% | −5.21% |
| May 4, 2026Q3 FY26 | $2.53 | $2.60 | +2.8% | $449.2M | $453.2M | +0.9% | −17.01% |
| Jan 29, 2026Q2 FY26 | $2.52 | $2.58 | +2.4% | $449.5M | $464.1M | +3.2% | −7.27% |
| Oct 30, 2025Q1 FY26 | $1.38 | $1.42 | +2.9% | $372.0M | $384.6M | +3.4% | +14.21% |
Financial highlights
| 12 quarters | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $444.4M | $505.0M | $384.6M | $464.1M | $453.2M | $484.1M | |
| Gross profit | $150.3M | $168.2M | $123.2M | $151.6M | $140.8M | $177.5M | |
| Operating income | $56.2M | $73.0M | $33.1M | $58.8M | $57.4M | $69.8M | |
| Net income | $41.1M | $52.7M | $20.6M | $38.7M | $40.2M | $55.2M | |
| Diluted EPS | $2.40 | $3.03 | $1.18 | $2.22 | $2.33 | $3.22 | |
| Gross margin | 33.8% | 33.3% | 32.0% | 32.7% | 31.1% | 36.7% | |
| Operating margin | 12.7% | 14.5% | 8.6% | 12.7% | 12.7% | 14.4% |
Fiscal years (4-quarter sums)FY22 $1.18B · FY23 $1.28B · FY24 $1.59B · FY25 $1.71B · FY26 $1.79B
Revenue by product · Q4 FY26
Revenue by geography · FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $359.8M · Total debt $1.00B · Total assets $2.50B · Shareholders' equity $833.0M
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 16.48M · Float 15.56M · 94.4% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 2.55M | 15.48% | 13F | Aug 7, 2026 |
| FMR LLC | 1.74M | 10.55% | 13F | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 1.27M | 7.72% | 13F | Aug 13, 2026 |
| Jupiter Topco LLC | 905.9K | 5.50% | 13F | Aug 14, 2026 |
| JANUS HENDERSON GROUP Ltd. | 905.9K | 5.50% | 13G | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 4, 2026 | Deepak Chopra | director | −20,000 | $281.84 |
| Feb 2, 2026 | Deepak Chopra | director | −20,000 | $250.91 |
| Nov 10, 2025 | Deepak Chopra | director, officer: EXECUTIVE CHAIRMAN | −20,000 | $285.74 |
| Nov 7, 2025 | James B. Hawkins | director | −1,500 | $283.15 |
| Nov 7, 2025 | Paul Keith Morben | officer: PRES., OPTOELECTRONICS DIV | −416 | $279.10 |
Peers
- iShares MSCI India Small-Cap ETF
Direct global rival in airport, cargo, and trace detection screening.
- Leidos
TSA logistics incumbent and major aviation, ETD, and cargo screening rival.
- Philips (ADR)
Scale leader in hospital patient monitoring and connected cardiac care.
- GE HealthCare
Global medtech scale leader in patient monitoring, ECG, and anesthesia.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| OSI Systems | $206.64 | −0.01% | $3.41B | 23.1 | 18.4 | 1.9 | −4.1% |
| iShares MSCI India Small-Cap ETF | $71.81 | 0.00% | $704.0M | — | — | — | — |
| Leidos | $141.00 | +0.31% | $17.69B | 13.1 | 11.6 | 1.0 | +7.2% |
| Philips (ADR) | $26.72 | +0.06% | $26.12B | 19.9 | 13.7 | 1.3 | −2.9% |
| GE HealthCare | $71.73 | −0.01% | $32.40B | 20.8 | 13.8 | 1.6 | +5.8% |
| Median | 19.9 | 13.7 | 1.3 | +5.8% |